Abstract

Review Article

8 Gy single dose radiotherapy for bone metastasis in COVID-19 pandemia period: Review

Bora Uysal*, Hakan Gamsız, Ferrat Dincoglan, Omer Sager, Selcuk Demiral and Murat Beyzadeoglu

Published: 2020-05-06 00:00:00 | Volume 4 - Issue 2 | Pages: 005-007.

Bone metastases in cancer patients are highly painful and decrease the quality of life for these group of population. Covid-19 pandemia is a global challenging issue that mostly affect the patients with immune suppression or having comorbid diseases older than 65 years old. The palliation and management of bone metastases varies from single dose to several fractionation. The main goal of this article is to decide that short or long term fit for the cancer patients with bone metastasis in the Covid-19 era. We reviewed the topic about the short course and long term radiotherapy in the patients with painful bone metastases via novel literature.

Read Full Article HTML DOI: 10.29328/journal.jro.1001032 Cite this Article Read Full Article Pdf

Similar articles

Role of HRCT Thorax in preoperative assessment of RT-PCR COVID-19 negative oral cancer patients

Published on: 22nd December, 2020

OCLC Number/Unique Identifier: 8872656815

Background: Oral cancer accounts for 30% of all types of cancer in India. Surgery is the mainstay of treatment but due to the recent outbreak of COVID-19, there is a partial or complete disruption of health services in the country. The initial delay in the treatment was due to cancellations of planned surgeries as per government regulations and reduction in public transportation. In the latter half of the initial relaxation of the lockdown, we formulated our institutional protocol for the surgical treatment of oral cancer patients. On admission, all patients were kept in isolated wards followed by RT-PCR (Reverse Transcriptase-Polymerase Chain Reaction) testing on the same day. RT-PCR negative patients are subjected to HRCT Thorax (High-resolution Computer Tomography). This ensured the safety of health care workers, patients, and patient attendees. Keeping this in mind, we did an observational study on the role of HRCT in the pre-operative screening of asymptomatic oral cancer patients.  Materials and methods: Retrospective analysis of prospectively collected data of 150 patients was done. HRCT reporting was done by two experienced senior radiologists of the Department of Radiology at our hospital. Results: The number of patients under the CO-RADS 1 category was 121 and CO-RADS 2 category was 29, according to CO-RADS classification. The results of RT-PCR and HRCT were compared and there was a 100% positive correlation between RT-PCR and HRCT Thorax. Conclusion: Our study supported the use of HRCT Thorax as a diagnostic tool in pre-operative screening of oral cancer patients for COVID 19, particularly in RT-PCR negative cases.
Cite this ArticleCrossMarkPublonsHarvard Library HOLLISGrowKudosResearchGateBase SearchOAI PMHAcademic MicrosoftScilitSemantic ScholarUniversite de ParisUW LibrariesSJSU King LibrarySJSU King LibraryNUS LibraryMcGillDET KGL BIBLiOTEKJCU DiscoveryUniversidad De LimaWorldCatVU on WorldCat

8 Gy single dose radiotherapy for bone metastasis in COVID-19 pandemia period: Review

Published on: 6th May, 2020

OCLC Number/Unique Identifier: 8592937425

Bone metastases in cancer patients are highly painful and decrease the quality of life for these group of population. Covid-19 pandemia is a global challenging issue that mostly affect the patients with immune suppression or having comorbid diseases older than 65 years old. The palliation and management of bone metastases varies from single dose to several fractionation. The main goal of this article is to decide that short or long term fit for the cancer patients with bone metastasis in the Covid-19 era. We reviewed the topic about the short course and long term radiotherapy in the patients with painful bone metastases via novel literature.
Cite this ArticleCrossMarkPublonsHarvard Library HOLLISGrowKudosResearchGateBase SearchOAI PMHAcademic MicrosoftScilitSemantic ScholarUniversite de ParisUW LibrariesSJSU King LibrarySJSU King LibraryNUS LibraryMcGillDET KGL BIBLiOTEKJCU DiscoveryUniversidad De LimaWorldCatVU on WorldCat

Addressing the disparities and the factors related to prolonged inpatient length of stay for solid tumor oncology patients during the COVID-19 pandemic: A narrative review

Published on: 17th September, 2021

Solid tumor oncology treatments are primarily performed in the outpatient setting. However, hospitalizations are inevitable due to complications of cancer and treatment-related toxicities. With rising health care spending, the length of hospital stay (LOS) is increasingly considered a proxy for healthcare costs. There are several ongoing efforts to abbreviate the inpatient LOS and ensure a safe and timely discharge to the outpatient setting. In addition to the acute illness and the associated comorbidities, various factors affect the LOS: social determinants of health (SDOH), nutritional status in cancer patients, and end-of-life issues. Furthermore, it is unclear how the institutional policies on social distancing and visitation during the current coronavirus disease (COVID-19) pandemic may impact the LOS. The purpose of this article is to review various factors and barriers that lead to longer LOS for solid tumor patients during the COVID-19 pandemic, and identify the critical areas of quality improvement.
Cite this ArticleCrossMarkPublonsHarvard Library HOLLISGrowKudosResearchGateBase SearchOAI PMHAcademic MicrosoftScilitSemantic ScholarUniversite de ParisUW LibrariesSJSU King LibrarySJSU King LibraryNUS LibraryMcGillDET KGL BIBLiOTEKJCU DiscoveryUniversidad De LimaWorldCatVU on WorldCat

References

  1. Latest news. Common questions about coronavirus outbreak. Cancer.
  2. Nielsen OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol. 1991; 9: 509-524. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1705581
  3. Goblirsch MJ, Zvolak PP, Clohisy DR. Biology of bone cancer pain. Clin Cancer Res. 2006; 12: 6231-6235. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17062706
  4. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of WHO guidelines for cancer pain relief: 10 year prospective study. Pain. 1995; 63: 65-76. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8577492
  5. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T, et al. Meta-analysis of dose-fractionation radiotherapy trials fort he palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003; 55: 594-605. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12573746
  6. Hoskin PJ, Price P, Easton D, Regan J, Austin D, et al. A prospective randomized trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol. 1992; 23: 74-78. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1372126
  7. Jeremic B, Shibamato Y, Acimovic L, Milicic B, Milisavljevic S, et al. A randomized trial of three single dose radition therapy regimens in the treatment of metstatic bone pain. Int J Radiat Oncol Biol Phys. 1998; 42: 161-167. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9747834
  8. Steenland E, Leer JW, van Houewelingen H, Post WJ, van den Hout WB, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone metastases study. Radiother Oncol. 1999; 52: 101-109. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10577695
  9. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, et al. Randomized trial of short-versus long course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005; 97: 798-804. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15928300
  10. Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, et al. RTOG 0631 Phase 2/3 study of image guided stereotactic radiosurgery for localized spine metastases: phase 2 results. Pract Radiat Oncol. 2014; 4: 76-81. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24890347
  11. Gertzen PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience of 500 cases from a single institution. Spine. 2007; 15: 193-199. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17224814
  12. Steven D, Jennifer T, Peter S, Bressel M, Kelly D, et al. Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: a prospective clinical trial. Breast. 2020; 49: 55-62. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31734589
  13. Laila AG, Whitney HB, James AH, Mancini B, Jagsi R, et al. Recommendations for single-fraction radiation therapy and stereotactic body radiation therapy in palliative treatment of bone metastasis: a statewide practice patterns survey. Pract Radiat Oncol. 2019; 9: 541-548. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31326530
  14. Shiloh R, Krishnan M. Radiation for treatment of painful bone metastasis. Hematol Oncol Clin North Am. 2018; 32: 459-468. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29729781

Indexing